SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)The company has lodged financial reports with ASIC. | 20/12/2024 |
The company notifies ASIC of changes to its share structure which may include changes to the class of shares (e.g. converting ordinary shares to preference shares), amendments to the terms on which shares are issued, or the consolidation/splitting of shares. | 20/12/2024 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
delisted from the commencement of trading on Wednesday, 8 July 2020, pursuant to Listing rule 17.12. | 08/07/2020 |
we understand this company failed and ASX removed the company from listing because its securities have been suspended from trading for an unacceptably long period | 08/07/2020 |
The company has been unable to meet the requirement for relisting on the ASX and will be removed from the official list in the coming days. The removal of HMO from trading follows the termination of an agreement regarding a proposed transaction which the company had developed to an advanced stage that would materially change the nature and scale of the company's activities. | 30/06/2020 |
The Annual General Meeting of the Company will be held at the Rokeby Room, BDO, 38 Station Street, Subiaco, Western Australia on Friday 31 July 2020 at 12.30 pm AWST. | 26/06/2020 |
The company's AGM will be held on 31 July 2020. The closing date for receipt of nominations from persons wishing to be considered for election as a Director is Friday, 12 June 2020. Any nominations must be received at the Company's registered office no later than 5.00 pm (Perth time) on Friday, 12 June 2020. | 04/06/2020 |
The company has deferred its AGM, which was scheduled to be held on 29 May 2020. The company expects to hold its AGM on or before 31 July 2020. | 26/05/2020 |
The company lodges its Quarterly Activity Report & Appendix 4C. | 30/04/2020 |
The company lodges its Annual Report to shareholders. | 24/04/2020 |
The Company's Annual General Meeting (AGM) will be held on Friday, 29 May 2020. The closing date for receipt of nominations from persons wishing to be considered for election as a Director is Wednesday, 8 April 2020. Any nominations must be received at the Company's registered office no later than 5.00 pm (Perth time) on Wednesday, 8 April 2020. | 31/03/2020 |
The company releases an Appendix 4G. | 27/02/2020 |
The company lodges its Appendix 4E & Annual Report. | 27/02/2020 |
The company lodges its Appendix 4C - quarterly. | 30/01/2020 |
The company confirms the expiry of 2,500,000 unlisted options, exercisable at $0.30 each on 2 December 2019. | 03/12/2019 |
The company lodges its Appendix 4C - quarterly. | 17/10/2019 |
The company lodges its Appendix 4D & Half-Year Financial Statements. | 27/08/2019 |
The company lodges an Appendix 4C - quarterly. | 23/07/2019 |
The company releases the results of its AGM. | 30/05/2019 |
The company lodges its Annual Report to Shareholders. | 23/04/2019 |
The Annual General Meeting of the Company will be held at the Rokeby Room, BDO, 38 Station Street, Subiaco, Western Australia on Thursday, 30 May 2019 at 11.00 am (WST). | 23/04/2019 |
The company lodges an Appendix 4C - quarterly. | 11/04/2019 |
The company's AGM will be held at the Rokeby Room, BDO, 38 Station Street, Subiaco, Western Australia at 11.00 am WST on Thursday, 30 May 2019. | 28/03/2019 |
The company releases an Appendix 4G. | 01/03/2019 |
The company lodges its Appendix 4E & Annual Financial Statements. | 01/03/2019 |
The company lodges its Appendix 4C - quarterly. | 31/01/2019 |
HearMeOutsigns binding IP License Agreement with AvidSys Infotech, granting exclusive and perpetual license of the HearMeOut platform to unlock potential of the platform throughout India and Asia. AvidSys investment of a minimum of AUD$2.0 million (and achieve five million active users on the HearMeOut platform) or AUD$3.5 million on application design, marketing, application services and business operations over four years. HearMeOut to receive a royalty of 5% of the net profit in each financial year (or part thereof, that the agreement remains in place. Agreement will see HearMeOut expand its platform into high-growth regions in a low risk fashion, with strong technical support and significant funding by AvidSys. HearMeOut to focus on growth activitiesthroughoutthe rest of world (i.e. Australia, US and Europe) with reduced operational overheads. Transaction provides HearMeOut exposure to AvidSys Group's strong internal technical and media team, who will be working together with HMO to achieve optimal operational outcomes. | 10/12/2018 |
The technical handover process with the former HMO Israel management is nearing completion and all required funds to allow settlement to occur has been remitted to HMO Israel. | 04/12/2018 |
The boardFollowing a detailed review of the HMO platform the board of HMO has determined that it wishes to continue to operate the HMO platform, albeit with a more conservative cost structure and with a different user / marketing strategy. A number of HMO Israel executives have continued to assist the Company for no financial benefit following their respective employment contracts being terminated, while HMO has continued to evaluate the path forward for the HMO platform. | 23/11/2018 |
The following securities will be released from escrow on 6 December 2018: Ordinary shares - 20,034,873; Options expiring 2/12/2019 - 2,500,000; Options expiring 2/12/2021 - 1,428,582; Class A Performance Options - 13,000,000; Class B Performance Options - 13,000,000; Class C Performance Options - 13,000,000; Class D Performance Options - 4,428,000. | 19/11/2018 |
The company lodges an Appendix 4C. | 29/10/2018 |
The company lodges its Appendix 4D & Half-Year Financial Statements. | 31/08/2018 |
Following a scheduled ASX internal system change affecting the Market Announcements Platform, it has been necessary to re-apply the "˜Suspend' session state. This announcement serves to re-confirm the securities of this entity remain suspended. | 06/08/2018 |
The company lodges its Appendix 4C - quarterly. | 31/07/2018 |
The company's 100% owned subsidiary HMO Israel has been placed on "˜care and maintenance', with immediate effect. All staff of HMO Israel have had their respective employment contracts terminated effective 12 July 2018 and are now completing their notice periods. In addition, the Company has terminated all influencer and general marketing contracts associated with the HearMeOut platform and has given notice in relation to leases and other related contracts. It is expected this action will see a saving of approximately USD$200,000 per calendar month for the Company moving forward. | 18/06/2018 |
HearMeOut Limited hereby requests an extension of the voluntary suspension of the Company's securities from commencement of trading on 15 June 2018, pending an announcement regarding a continuing strategic review of the operation of the HearMeOut platform. The announcement is expected to be made on or before commencement of trading on 22 June 2018. | 15/06/2018 |
The company requests an extension of its voluntary suspension until it makes an announcement to the market, which it expects to make on or before commencement of trading on 15 June 2018. | 01/06/2018 |
The company releases the results of its AGM. | 29/05/2018 |
The extension of the voluntary suspension is requested until the Company makes the Announcement to the market, which it expects to make on or before commencement of trading on Friday, 1 June 2018. | 25/05/2018 |
The securities of HearMeOut Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a continuing strategic review of the operation of the HearMeOut platform. | 21/05/2018 |
listed entity carried for record purposes only | 06/12/2016 |
This is the worst company ever, which had the business for less than 15 minutes. My 18 year old bought the shares from her hard earned money, thinking being responsible and investing. Although a great lesson to do research, this company has been atrocious. The directors have no shame sending request to get reelected and increase their earnings. ASX needs to use better discretion before letting firms like these enter the platform. | 04/08/2020 18:16:16 |
Shares suspended! So now HMO have direct control of my share investment. This is damn annoying for a retiree who relies on buy and sell for income. | 18/06/2018 17:51:50 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 14/07/2017 | Anton Uvarov | 250,000 | $0.154 | $38,563.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Glenn Whiddon | Non Exec Chairman | 11/09/2017 |
| Howard Digby | Non Exec Director | 04/12/2018 |
| David Tasker | Executive Director | 11/09/2017 |
| Peter Webse | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
